XML 22 R12.htm IDEA: XBRL DOCUMENT v3.19.1
Note 6 - Stock-based Compensation
3 Months Ended
Mar. 31, 2019
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]
NOTE
6
– STOCK-BASED COMPENSATION
 
The Company has fully vested stock options outstanding under the
2001
Stock Option Plan and vested and unvested stock options and restricted stock awards under the
2017
Equity Incentive Plan.
 
A summary of stock option activity during the
three
months ended
March 31, 2019
and
2018
is presented below:
 
   
For the three Months Ended March 31, 2019
 
                   
Average
 
     
 
   
Weighted-
   
Remaining
 
     
 
   
Average
   
Contractual
 
   
Shares
   
Exercise Price
   
Term (years)
 
                         
Outstanding, December 31, 2018
 
 
164,410
   
$
14.69
   
 
5.8
 
Granted
 
 
1,000
   
 
14.63
   
 
 
 
Exercised
 
 
-
   
 
-
   
 
 
 
Forfeited or expired
 
 
-
   
 
-
   
 
 
 
                         
Outstanding, March 31, 2019
 
 
165,410
   
$
14.69
   
 
5.6
 
                         
Exercisable, March 31, 2019
 
 
38,690
   
$
13.93
   
 
4.7
 
 
   
For the three Months Ended March 31, 2018
 
                   
Average
 
     
 
   
Weighted-
   
Remaining
 
     
 
   
Average
   
Contractual
 
   
Shares
   
Exercise Price
   
Term (years)
 
                         
Outstanding, December 31, 2017
   
207,108
    $
14.18
     
6.2
 
Granted
   
5,000
     
15.48
     
 
 
Exercised
   
-
     
-
     
 
 
Forfeited or expired
   
(1,002
)    
14.90
     
 
 
                         
Outstanding, March 31, 2018
   
211,106
    $
14.28
     
5.9
 
                         
Exercisable, March 31, 2018
   
28,456
    $
9.65
     
1.3
 
 
 
The exercise price of outstanding stock options at
March 31, 2019
range from
$9.65
to
$15.48
per share. The grant date fair value of stock options awarded in the
three
months ended
March 31, 2019
was
$3.77
using the Black-Scholes-Merton options pricing model with the following inputs and assumptions:
 
Grant date stock price
  $
14.63
 
Dividend yield
   
0.00
%
Expected volatility
   
19.55
%
Risk-free interest rate
   
2.63
%
Expected life in years
   
6
 
 
A summary of restricted stock activity during the
three
months ended
March 31, 2019
and
2018
is presented below:
 
           
Weighted
   
Average
 
           
Average
   
Remaining
 
           
Grant Date
   
Contractual
 
   
Shares
   
Price
   
Term (years)
 
                         
   
For the Quarter Ended March 31, 2019
 
                         
Outstanding, December 31, 2018
 
 
49,829
   
$
14.90
   
 
4.0
 
                         
Granted
 
 
-
   
 
-
   
 
 
 
Vested
 
 
-
   
 
-
   
 
 
 
Forfeited or expired
 
 
-
   
 
-
   
 
 
 
                         
Outstanding, March 31, 2019
 
 
49,829
   
$
14.90
   
 
3.8
 
 
   
For the Quarter Ended March 31, 2018
 
                         
Outstanding, December 31, 2017
   
74,750
    $
14.90
     
4.9
 
                         
Granted
   
429
     
15.48
     
 
 
Vested
   
-
     
-
     
 
 
Forfeited or expired
   
-
     
-
     
 
 
                         
Outstanding, March 31, 2018
   
75,179
    $
14.90
     
4.7
 
 
Compensation and benefits included
$75,000
and
$86,000
of stock-based expense for the
three
months ended
March 31, 2019
and
2018,
respectively.
 
As of
March 31, 2019,
there was
$1,130,000
of total unrecognized stock-based expense including
$448,000
related to unvested stock options and
$682,000
from restricted stock awards granted under the
2017
Equity Incentive Plan that is expected to be recognized over the next
3.7
years.